Lundbeck eyes progress in 2022, disappoints compared to consensus
On Wednesday morning, Lundbeck has publicized its full-year financial figures for 2021. Sales of core products grew by 15 percent, but the company is still handing in results slightly below expectations.
by marketwire, translated by daniel pedersen
On Wednesday, pharmaceutical firm Lundbeck has released its full-year financial figures for 2021.